Clinical trials: SBP - Spontaneous Bacterial Peritonitis
Spontaneous Bacterial Peritonitis
Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure
1. All consecutive patients with Cirrhosis and ascites admitted to ILBS (Institute of Liver \& Biliary Sciences) will be evaluated for the presence of SBP (Spontaneous Bacterial Peritonitis) by ascitic fluid examination at…
- Trial name
- NCT01852630
- Testing
- cefepime + Albumin, Imipenem + Albumin
- Where
- India
- Volunteers
- 175 people
- Sponsor
- Institute of Liver and Biliary Sciences, India
Spontaneous Bacterial Peritonitis
Serum Copeptin in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
Current reports have demonstrated that copeptin predicts disease progression and prognosis in cirrhotic patients, independent of liver-specific scoring systems.
- Trial name
- NCT05401721
- Testing
- Serum copeptin
- Where
- Egypt
- Volunteers
- 89 people
- Sponsor
- Sohag University
Decompensated Cirrhosis, Small Bowel Bacterial Overgrowth Syndrome
Primary Prophylaxis for Spontaneous Bacterial Peritonitis
Patient with liver cirrhosis commonly have co-existing small bowel bacterial overgrowth (SIBO) yet may be asymptomatic. It is unclear as to the value of treating SIBO in asymptomatic individuals.
- Trial name
- SIBOC (NCT04775329)
- Testing
- Rifaximin
- Where
- Singapore
- Volunteers
- 2 people
- Sponsor
- Changi General Hospital
Spontaneous Bacterial Peritonitis, Cirrhoses, Liver
Comparative Study of Secondary Prophylaxis for SBP
The goal of this clinical trial is to learn if norfloxacin, nitazoxanide, and colistin work as secondary prophylactic agents for spontaneous bacterial peritonitis (SBP) in cirrhotic patients with ascites.
- Conditions
- Spontaneous Bacterial Peritonitis, Cirrhoses, Liver, Ascites
- Trial name
- 3C-SPS (NCT06827756)
- Testing
- Norfloxacin 400 MG, Nitazoxanide 500 MG, Colistin
- Where
- Egypt
- Volunteers
- 90 people
- Sponsor
- Tanta University
Spontaneous Bacterial Peritonitis
Diagnosis of Spontaneous Bacterial Peritonitis
The study is aimed to revise the current criteria for the diagnosis of spontaneous bacterial peritonitis and the decisional thresholds to start treatment.
- Trial name
- ARSDIASP (NCT01598870)
- Testing
- Diagnostic tests
- Where
- Italy
- Volunteers
- 100 people
- Sponsor
- Azienda Ospedaliera di Lecco
Spontaneous Bacterial Peritonitis
Asymptomatic Spontaneous Bacterial Peritonitis in Patients With Decompensated Liver Cirrhosis
Spontaneous bacterial peritonitis is defined as the presence of an infection in a previously sterile ascites in the absence of an intra-abdominal source of infection or malignancy .
- Trial name
- NCT03163745
- Testing
- paracentesis
- Where
- Egypt
- Volunteers
- 70 people
- Sponsor
- Assiut University
Spontaneous Bacterial Peritonitis
Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)
Study Design: Double-blind placebo-controlled clinical trial Study Duration:2 years Study Center: Hospital de la Santa Creu i Sant Pau, Barcelona (single center) Objectives: To assess the effect of adjunctive Vivomixx® on…
- Trial name
- NCT02552862
- Testing
- Vivomixx®
- Where
- Spain
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Proton Pump Inhibitor Adverse Reaction, Liver Cirrhosis
Proton Pump Inhibitors in Cirrhotic Patients
Proton pump inhibitors (PPIs) inappropriate use, in patients with cirrhosis, presents a significant clinical challenge. This study evaluates overprescription and misuse of PPIs in cirrhotic patients.
- Trial name
- NCT06384443
- Where
- Egypt
- Volunteers
- 1,000 people
- Sponsor
- National Liver Institute, Egypt
Cirrhosis, Ascites
Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites
We wish to perform a multicenter, double-blind RCT with two parallel-group stratified on the center, comparing rifaximin to no rifaximin (placebo) for the primary prophylaxis of SBP in 'severe' cirrhotic patients with large…
- Conditions
- Cirrhosis, Ascites, Peritonitis
- Trial name
- ProPILARifax (NCT03069131)
- Testing
- Rifaximin
- Where
- 18 sites in France
- Volunteers
- 160 people
- Sponsor
- Centre Hospitalier Universitaire de Besancon
End Stage Liver Disease, Infection
A Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIP Study)
Spontaneous bacterial peritonitis (SBP) is a common complication of end-stage liver disease due to various causes. The initial anti-infective medication is appropriate and the patient's survival rate is closely related.
- Conditions
- End Stage Liver Disease, Infection, Spontaneous Bacterial Peritonitis
- Trial name
- NCT03362632
- Testing
- Antibiotics
- Where
- China
- Volunteers
- 400 people
- Sponsor
- Tongji Hospital
Spontaneous Bacterial Peritonitis, Cirrhosis
Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP)
Spontaneous bacterial peritonitis (SBP) is a common and frequently fatal complication of end-stage liver disease with a mortality of up to 10%, primarily due to the development of kidney failure.
- Trial name
- NCT00761098
- Testing
- Standard Care, Experimental
- Where
- 2 sites in United States
- Volunteers
- 80 people
- Sponsor
- Weill Medical College of Cornell University
Spontaneous Bacterial Peritonitis
Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis
One of the most common and serious complications in decompensated cirrhotic patients (DCPs) is bacterial infection.The most common infections in DCPs are cases of spontaneous bacterial peritonitis (SBP), which account for 40% 70%…
- Trial name
- NCT02759497
- Testing
- serum amyloid A level
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Tanta University
Cirrhosis
Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
Spontaneous bacterial peritonitis (SBP) present in cirrhotic patients induces severe circulatory dysfunction, which results in renal failure in up to 30% of the patients.
- Trial name
- Infecir (NCT00124228)
- Testing
- Human Albumin
- Where
- Spain
- Volunteers
- 110 people
- Sponsor
- Hospital Clinic of Barcelona